Kouji Chiba

Kobe University

Papers

1

Total Citations

2

H-Index

1

About

Kouji Chiba is a clinical researcher whose work centers on pediatric oncology, with a particular focus on the long-term complications of childhood cancer treatments. His research addresses the critical area of secondary malignant neoplasms, especially renal cell carcinoma (RCC) arising after chemoradiotherapy for childhood nephroblastoma. In his most cited work, a 2023 case report, Chiba documents a rare instance of RCC with a TFE3 gene translocation in the contralateral kidney of a patient previously treated for Wilms tumor. This contribution highlights the importance of vigilant long-term surveillance for survivors of childhood cancer, as secondary RCC, while uncommon, remains a significant risk. By detailing the genetic and clinical features of this case, Chiba’s work provides valuable guidance for clinicians monitoring pediatric cancer survivors. Although his citation count is currently modest, his findings underscore a crucial clinical message: the necessity of considering secondary malignancies in follow-up care. Chiba’s research bridges pediatric oncology and nephrology, offering insights that can improve patient outcomes through early detection and informed management of treatment-related complications.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Renal cell carcinoma in the contralateral kidney with <scp>TFE3</scp> gene translocation following chemotherapy for childhood nephroblastoma: A case report and literature review
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Kobe University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago